Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Coronary stent Stories

2013-07-29 23:03:54

One of a Select Number of U.S. Centers Testing a "disappearing" Device That’s Absorbed by the Body Royal Oak, MI (PRWEB) July 29, 2013 Beaumont Health System has joined a multicenter, international research study of a new temporary heart device that helps keep an artery open following angioplasty, then is broken down and absorbed by the body. The research will compare the effectiveness of the new “disappearing” device, the AbsorbTM Bioresorbable Vascular Scaffold made by...

2013-07-29 08:26:51

BOSTON and TEL AVIV, Israel, July 29, 2013 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("Inspire" or the "Company"), a leader in embolic protection stents, said the first patient has been enrolled in the Master II IDE clinical trial to evaluate the safety and effectiveness of the MGuard(TM) Prime Embolic Protection Stent (EPS) in patients suffering from ST Elevation Myocardial Infarction (STEMI). The multi-center, randomized trial is expected to include up to 70 sites in the...

2013-07-18 08:29:30

More Mature Markets in Western Europe Will See Marginal Declines, According to Millennium Research Group TORONTO, July 18, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, markets for interventional cardiology (IC) devices have reached maturation in Belgium, Sweden, Switzerland and the Netherlands, while Eastern European markets will continue to see growth. Procedure volume growth will be slight in...

2013-07-17 12:26:47

Importance of Coronary Artery Healing, Causes and Risk Factors of Delayed or Impaired Healing Are Focus of Website NEW YORK, July 17, 2013 /PRNewswire/ -- A new website, HeartVesselHealing.com, was launched today as an educational resource for patients and healthcare professionals regarding the risks associated with delayed arterial healing following coronary stent implantation. The website provides information about the importance of coronary artery healing following stent...

2013-07-15 23:16:40

Transparency Market Research Published new "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)" market research report to its report store. Browse the report; visit http://www.transparencymarketresearch.com/coronary-stents-market.html Albany, New York (PRWEB) July 15, 2013 According to Transparency Market Research “Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)”Global Coronary Stents market...

2013-07-10 12:27:24

-- Enhanced Deliverability with New Stent Delivery System ABBOTT PARK, Ill., July 10, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has approved the XIENCE Xpedition(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD), the most common form of heart disease.(i )XIENCE Xpedition is supported by the robust clinical evidence of the XIENCE family of drug eluting stents...

2013-07-10 10:21:08

Emmanouil S. Brilakis, M.D., Ph.D., of the VA North Texas Health Care System and University of Texas Southwestern Medical Center at Dallas, and colleagues conducted a review of medical literature regarding optimal medical therapy after percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries). The researchers identified 91 studies for inclusion in the review. "Percutaneous coronary intervention is commonly...

2013-07-09 23:29:31

International Leader in Cardiology to Help Advance Adult Stem Cell Therapy Treatment for Heart Disease Freeport, The Bahamas (PRWEB) July 09, 2013 Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has announced that Antonio Colombo, M.D., F.A.C.C. has joined the esteemed group of Okyanos’ medical advisory council members. Dr. Colombo is director of the Cardiac...

2013-06-27 23:18:21

High growth in smaller segments of the European interventional cardiology market contributes to continued increase and development of the total market. Vancouver, BC (PRWEB) June 27, 2013 Heart disease is a major cause of death and hospitalization in several European countries, as observed in a 2012 OECD (Organisation for Economic Co-Operation and Development) study. While previous methods for treating obstructed coronary arteries involved open-chest surgery, this is no longer the case...

2013-06-11 12:28:17

- Trial to Study the Innovative "Dissolving" Heart Device Compared to Abbott's Market-Leading Drug Eluting Stents in Patients with Coronary Artery Disease in Japan ABBOTT PARK, Ill., June 11, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has initiated the ABSORB Japan randomized controlled clinical trial to evaluate the Absorb(TM) Bioresorbable Vascular Scaffold (BVS) in patients with coronary artery disease (CAD), the most common form of heart disease.(1) The...